Sanofi outdoor building sign
Sanofi made two changes to its conditions on 340B pricing when health centers and certain hospitals use contract pharmacies.

Sanofi Makes Two Big Changes to its 340B Contract Pharmacy Policy

Drug manufacturer Sanofi has made two major changes to its conditions on 340B pricing when health centers and certain hospitals and use contract pharmacies, a company spokesperson confirms. One is raising flags among 340B providers and the other appears to be the first of its kind and may be welcomed by covered entities.

The company requires health centers, disproportionate share hospitals, critical access hospitals, rural referral centers, and sole community hospitals that wish to dispense 340B-purchased Sanofi drugs at more than one contract pharmacy to submit claims data to Sanofi’s third-party vendor 340B ESP for those products filled by those pharmacies. If an affected entity declines to provide the data and lacks an in-house pharmacy, it can designate a single contract pharmacy to dispense 340B-purchased Sanofi drugs.

Drug manufacturer Sanofi has made two major changes to its conditions on 340B pricing when health centers and certain hospitals and use contract pharmacies, a company spokesperson confirms.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer